Table 5.
Other complications seen in the two groups.
| Group A | Group B | |
|---|---|---|
| Death | 1 | 1 |
| Asymptomatic DVT | 3 | 1 |
| Symptomatic DVT | 1 | 0 |
| CVA/stroke | 0 | 0 |
| MI/Acute coronary syndrome | 1 | 1 |
| Deranged renal function tests | 4 | 3 |
Group A: TXA group; Group B: Control group.
Other complications seen in the two groups.
| Group A | Group B | |
|---|---|---|
| Death | 1 | 1 |
| Asymptomatic DVT | 3 | 1 |
| Symptomatic DVT | 1 | 0 |
| CVA/stroke | 0 | 0 |
| MI/Acute coronary syndrome | 1 | 1 |
| Deranged renal function tests | 4 | 3 |
Group A: TXA group; Group B: Control group.